Anda's Opioid Sales Were In DEA's 'Bull's-Eye,' Jury Is Told
Jurors in a New York opioid-crisis trial heard Tuesday that drug distributor Anda had so many regulatory issues that the U.S. Drug Enforcement Administration had the company "in its bull's-eye" —...To view the full article, register now.
Already a subscriber? Click here to view full article